Share

Access to Health Care Press Releases

July 16, 2018

ACS CAN Letter: Drug Pricing Policy Should Prioritize Patient Affordability

Today the American Cancer Society Cancer Action Network submitted comments to the Department of Health and Human Services (HHS) regarding proposals to reduce prescription drug costs outlined in the administration’s Request for Information (RFI) regarding its Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (blueprint).

June 14, 2018

Patient Groups: Uphold Health Care Law As Congress Intended

Patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae or friend of the court brief in the U.S. District Court case, Texas v. United States, citing the devastating impact patients would face should the court side with plaintiffs and move to invalidate the Affordable Care Act. 

June 7, 2018

Virginia Becomes 33rd State to Increase Access to Health Coverage through Medicaid

Today Virginia governor Ralph Northam signed into law a state budget that extends health care coverage to an estimated 400,000 low-income Virginians through the Medicaid program. Virginia is now the 33rd state, in addition to Washington, D.C., to accept federal funding to provide health insurance coverage to adults earning less than 138 percent of the federal poverty level—just under $17,000 a year for a single adult. As part of the expansion, Virginia will require Medicaid recipients attend school, work, partake in job training or engage in some kind of community engagement for upwards of 80 hours a month in order to receive benefits. This requirement could pose significant challenges to cancer patients and survivors.

May 22, 2018

Patient Safety in Jeopardy Under Senate Right-to-Try Proposal

The American Cancer Society Cancer Action Network (ACS CAN), Friends of Cancer Research (FOCR), and the National Organization for Rare Disorders (NORD) along with more than 100 advocacy groups representing millions of patients submitted a letter to Members of the House of Representatives strongly opposing the Senate Right-to-Try Act (S. 204).